• 2021-04-14 问题

    AU2010209650(A1)KeyintermediatesforthesynthesisofRosuvastatinorpharmaceuticallyacceptablesaltsthereof.Inventor(s):ZDENKOCASARJANEZKOSMRLJ(CASAR,ZDENKO,KOSMRLJ,JANEZ)Applicant(s):LEKPHARMACEUTICALS(LEKPHARMACEUTICALSD.D)Classification:-international:A61K31/505A61P3/06C07D239/42-European:C07D239/42从上述信息判断该文献的文献类型为:

    AU2010209650(A1)KeyintermediatesforthesynthesisofRosuvastatinorpharmaceuticallyacceptablesaltsthereof.Inventor(s):ZDENKOCASARJANEZKOSMRLJ(CASAR,ZDENKO,KOSMRLJ,JANEZ)Applicant(s):LEKPHARMACEUTICALS(LEKPHARMACEUTICALSD.D)Classification:-international:A61K31/505A61P3/06C07D239/42-European:C07D239/42从上述信息判断该文献的文献类型为:

  • 2022-06-06 问题

    The core of the European monetary system is( )。 A: European exchange rate mechanism B: European monetary unit C: European monetary fund D: European central bank

    The core of the European monetary system is( )。 A: European exchange rate mechanism B: European monetary unit C: European monetary fund D: European central bank

  • 2022-06-06 问题

    The core of the European monetary system is( ) A: European Currency Unit B: European central exchange rate system C: European Monetary Fund D: European Central Bank

    The core of the European monetary system is( ) A: European Currency Unit B: European central exchange rate system C: European Monetary Fund D: European Central Bank

  • 2022-06-15 问题

    The European Union (EU) is an organization of 15 () that promotes cooperation among its members. A: European countries B: developed countries C: Western European countries D: Southern European countries

    The European Union (EU) is an organization of 15 () that promotes cooperation among its members. A: European countries B: developed countries C: Western European countries D: Southern European countries

  • 2022-06-06 问题

    The Council of the European Union is one of two legislative bodies and together with the European Parliament serves to amend and approve the proposals of the European Commission.( )

    The Council of the European Union is one of two legislative bodies and together with the European Parliament serves to amend and approve the proposals of the European Commission.( )

  • 2022-06-06 问题

    3.What is the European commission considering?The European commissions is ______________ a French and German aid ______________ worth $543 billion to aid European Union countries ______________ by the coronavirus.

    3.What is the European commission considering?The European commissions is ______________ a French and German aid ______________ worth $543 billion to aid European Union countries ______________ by the coronavirus.

  • 2022-06-06 问题

    European Union is the political and Economic Union in Europe developed from European Community.

    European Union is the political and Economic Union in Europe developed from European Community.

  • 2021-04-14 问题

    AU2010209650 (A1) Key intermediates for the synthesis of Rosuvastatin or pharmaceutically acceptable salts thereof . Inventor(s): ZDENKO CASAR; JANEZ KOSMRLJ + (CASAR, ZDENKO, ; KOSMRLJ, JANEZ) Applicant(s): LEK PHARMACEUTICALS + (LEK PHARMACEUTICALS D.D) Classification: - international: A61K31/505; A61P3/06; C07D239/42 - European: C07D239/42 从上述信息判断该文献的文献类型为:

    AU2010209650 (A1) Key intermediates for the synthesis of Rosuvastatin or pharmaceutically acceptable salts thereof . Inventor(s): ZDENKO CASAR; JANEZ KOSMRLJ + (CASAR, ZDENKO, ; KOSMRLJ, JANEZ) Applicant(s): LEK PHARMACEUTICALS + (LEK PHARMACEUTICALS D.D) Classification: - international: A61K31/505; A61P3/06; C07D239/42 - European: C07D239/42 从上述信息判断该文献的文献类型为:

  • 2021-04-14 问题

    AU2010209650 (A1) Key intermediates for the synthesis of Rosuvastatin or pharmaceutically acceptable salts thereof . Inventor(s): ZDENKO CASAR JANEZ KOSMRLJ (CASAR, ZDENKO, KOSMRLJ, JANEZ) Applicant(s): LEK PHARMACEUTICALS (LEK PHARMACEUTICALS D.D) Classification: - international: A61K31/505 A61P3/06 C07D239/42 - European: C07D239/42 从上述信息判断该文献的文献类型为:

    AU2010209650 (A1) Key intermediates for the synthesis of Rosuvastatin or pharmaceutically acceptable salts thereof . Inventor(s): ZDENKO CASAR JANEZ KOSMRLJ (CASAR, ZDENKO, KOSMRLJ, JANEZ) Applicant(s): LEK PHARMACEUTICALS (LEK PHARMACEUTICALS D.D) Classification: - international: A61K31/505 A61P3/06 C07D239/42 - European: C07D239/42 从上述信息判断该文献的文献类型为:

  • 2022-06-06 问题

    within the European Union.

    within the European Union.

  • 1 2 3 4 5 6 7 8 9 10